{"database": "lobbying", "table": "lobbying_activities", "rows": [[1626351, "b7ed1477-db90-46de-9cc4-93eb549dbc20", "Q4", "SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING", 35968, "SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING", 2014, "fourth_quarter", "PHA", "Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204).", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE", null, 90000, 0, 0, "2015-01-16T15:56:01.213000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1626351"], "units": {}, "query_ms": 0.2872829791158438, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}